Inequalities associated with emergence of Delta SARS-CoV-2 variant of concern (B.1.617.2) in England: awareness for future variants

por Leeman, D., Campos-Matos, I., Dabrera, G.
Publicado 2022

Gene Expression Dosage Regulation in an Allopolyploid Fish

por Matos, I, Machado, M. P., Schartl, M., Coelho, M. M.
Publicado 2015

Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1–4 inhibitor in patients with advanced solid tumors

por Bahleda, R., Meric-Bernstam, F., Goyal, L., Tran, B., He, Y., Yamamiya, I., Benhadji, K. A., Matos, I., Arkenau, H.-T.
Publicado 2020

Rapid rise in COVID-19 among young people in England – learning for the future

por Twohig, K.A., Zaidi, A., Campos-Matos, I., Hope, R., Hall, J., Chudasama, D., Sinnathamby, M., Fitzpatrick, J., Dabrera, G., Mohammed, H.
Publicado 2023

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with ref...

por Ochsenreither, S., Fiedler, W.M., Conte, G.D., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K.F., Saavedra, O., Baumeister, H., Zurlo, A., Garralda, E.
Publicado 2022